L & S Advisors’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q2
Sell
-5,903
Closed -$527K 350
2018
Q1
$527K Sell
5,903
-7,211
-55% -$692K 0.1% 184
2017
Q4
$1.37M Sell
13,114
-21,150
-62% -$2.39M 0.21% 105
2017
Q3
$5M Buy
34,264
+26,849
+362% +$3.66M 0.84% 48
2017
Q2
$963K Sell
7,415
-22,971
-76% -$2.81M 0.17% 128
2017
Q1
$3.78M Buy
+30,386
New +$3.64M 0.72% 36
2016
Q1
Sell
-32,896
Closed -$3.94M 111
2015
Q4
$3.94M Sell
32,896
-1,201
-4% -$139K 0.99% 39
2015
Q3
$3.69M Buy
34,097
+15,757
+86% +$1.96M 1.07% 41
2015
Q2
$2.12M Buy
18,340
+185
+1% +$21.1K 0.54% 65
2015
Q1
$2.09M Buy
+18,155
New +$2.17M 0.55% 68
2014
Q4
Sell
-40,764
Closed -$3.86M 90
2014
Q3
$3.86M Buy
+40,764
New +$3.68M 1.89% 16
2014
Q1
Sell
-47,082
Closed -$3.98M 112
2013
Q4
$3.98M Buy
+47,082
New +$3.73M 1.44% 28

Other funds holding CELG

L & S Advisors's CELG Position: Q2 2018 in Review

L & S Advisors sold out of Celgene Corp (CELG) in Q2 2018, closing a stake of 5,903 shares — an estimated $527K sold.

L & S Advisors first reported a position in CELG in Q4 2013 and held it in 11 quarters. The position peaked at $5M in Q3 2017. 1,360 funds tracked by Wall St. Rank hold CELG as of Q2 2018.

  • L & S Advisors reported no remaining Celgene Corp position as of Q2 2018 after selling out during the quarter.
  • L & S Advisors sold 5,903 Celgene Corp shares in Q2 2018, an estimated $527K.
  • L & S Advisors first reported a position in Celgene Corp in Q4 2013 and held it in 11 quarters.
  • L & S Advisors's Celgene Corp position peaked at $5M in Q3 2017.
  • 1,360 funds tracked by Wall St. Rank held Celgene Corp as of Q2 2018.

Based on L & S Advisors's 13F filing for Q2 2018, filed 13 Aug 2018.